BCAA insufficiency leads to premature ovarian insufficiency via ceramide-induced elevation of ROS

EMBO Mol Med. 2023 Apr 11;15(4):e17450. doi: 10.15252/emmm.202317450. Epub 2023 Feb 27.

Abstract

Premature ovarian insufficiency (POI) is a disease featured by early menopause before 40 years of age, accompanied by an elevation of follicle-stimulating hormone. Though POI affects many aspects of women's health, its major causes remain unknown. Many clinical studies have shown that POI patients are generally underweight, indicating a potential correlation between POI and metabolic disorders. To understand the pathogenesis of POI, we performed metabolomics analysis on serum and identified branch-chain amino acid (BCAA) insufficiency-related metabolic disorders in two independent cohorts from two clinics. A low BCAA diet phenotypically reproduced the metabolic, endocrine, ovarian, and reproductive changes of POI in young C57BL/6J mice. A mechanism study revealed that the BCAA insufficiency-induced POI is associated with abnormal activation of the ceramide-reactive oxygen species (ROS) axis and consequent impairment of ovarian granulosa cell function. Significantly, the dietary supplement of BCAA prevented the development of ROS-induced POI in female mice. The results of this pathogenic study will lead to the development of specific therapies for POI.

Keywords: ROS; ceramide; infertility; low BCAA diet; premature ovarian insufficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids
  • Animals
  • Female
  • Humans
  • Menopause, Premature*
  • Mice
  • Mice, Inbred C57BL
  • Primary Ovarian Insufficiency* / chemically induced
  • Primary Ovarian Insufficiency* / pathology
  • Primary Ovarian Insufficiency* / therapy
  • Reactive Oxygen Species

Substances

  • Reactive Oxygen Species
  • Amino Acids

Associated data

  • GEO/GSE215358